“People who do use e-cigarette products should monitor themselves for symptoms such as cough, shortness of breath, chest pain, nausea and vomiting, and promptly seek medical attention for any health concerns,” Meaney-Delman advised.
Action by White House
As concern grows over the outbreak of lung illnesses tied to vaping, the Trump administration on Wednesday said it would move to ban flavored versions of e-cigarettes.
Vaping is harming young people and “we’re going to have to do something about it,” President Donald Trump said at the Oval Office, The New York Times reported. He was flanked by Alex Azar, the secretary of Health and Human Services, and Dr. Ned Sharpless, the acting Food and Drug Administration commissioner.
Trump noted that he and his wife Melania have a teenaged son, Barron, and Melania “feels very strongly” about the vaping issue.
Azar told reporters that details of a plan to phase out flavored e-cigarettes from the market will be announced over the next few weeks. In a tweet, he added that “new provisional data show that youth use continues to rise rapidly, and we will not stand idly by.”
These days, U.S. teens are more likely to vape than to smoke, according to the U.S. National Institute on Drug Abuse. Among high school seniors, 16% say they used e-cigarettes in the past month, while only 11% smoked.
The White House’s move comes after similar legal attempts by states to curb an enormous surge in teen vaping.
This week Michigan became the first state to ban flavored e-cigarettes, which come in candy, fruit and other enticing flavors attractive to youth.
And earlier this year, San Francisco became the first major city to ban e-cigarette sales altogether. Juul Labs, the leading maker of vaping products, is challenging that ban via a ballot initiative set to go to voters in November.
An all-out ban?
One lung expert says the White House’s proposed ban on flavored e-cigarettes doesn’t go far enough, however.
“There is no guarantee of safety with any vaping, including the commercially sold nicotine products and devices,” said Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City.